Severe Pulmonary Arterial Hypertension
1 clinical trials · Condition
◉ Watch Severe Pulmonary Arterial Hypertension
| Record | Firm | Date |
|---|---|---|
| Open-label, Multi-center Protocol to Provide QTI571 to PAH Patients Who Participated in the Extension Study (A2301E1) in Japan (NCT02042014) | Novartis Pharmaceuticals | 2014-01-22 |
Track Severe Pulmonary Arterial Hypertension automatically
Every clearance here is in the API, with alerts when new ones post.